These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20885074)

  • 1. [Nano-safety science for assuring the safety of nanomaterials].
    Yoshioka Y; Yoshikawa T; Tsutsumi Y
    Nihon Eiseigaku Zasshi; 2010 Sep; 65(4):487-92. PubMed ID: 20885074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nanosafety studies of nanomaterials about biodistribution and immunotoxicity].
    Yoshioka Y
    Yakugaku Zasshi; 2011 Feb; 131(2):221-4. PubMed ID: 21297365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety assessment of nanomaterials in reproductive developmental field].
    Yamashita K; Yoshioka Y
    Yakugaku Zasshi; 2012; 132(3):331-5. PubMed ID: 22382838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety assessment of nanomaterials for development of nano-cosmetics].
    Yoshida T; Yoshioka Y; Tsutsumi Y
    Yakugaku Zasshi; 2012; 132(11):1231-6. PubMed ID: 23123712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent topics about nano-safety science and its future].
    Yoshioka Y; Yoshikawa T; Nabeshi H; Tsutsumi Y
    Yakugaku Zasshi; 2013; 133(2):169-74. PubMed ID: 23370508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety assessment of nanomaterials using toxicokinetics and toxicoproteome analysis].
    Nabeshi H; Yoshikawa T; Imazawa T; Tsunoda S; Tsutsumi Y
    Yakugaku Zasshi; 2010 Apr; 130(4):465-70. PubMed ID: 20371987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems.
    Shvedova AA; Kagan VE; Fadeel B
    Annu Rev Pharmacol Toxicol; 2010; 50():63-88. PubMed ID: 20055698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transdermal penetration and biodistribution of nanomaterials and their acute toxicity in vivo].
    Tsunoda S
    Yakugaku Zasshi; 2011 Feb; 131(2):203-7. PubMed ID: 21297362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nano-safety science for sustainable nanotechnology].
    Yoshioka Y; Tsutsumi Y
    Yakugaku Zasshi; 2014; 134(6):737-42. PubMed ID: 24882650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of nanosafety forecasting system from the viewpoint of nanomaterial-protein interaction].
    Yoshikawa T
    Yakugaku Zasshi; 2011 Feb; 131(2):209-13. PubMed ID: 21297363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies.
    Landsiedel R; Sauer UG; Ma-Hock L; Schnekenburger J; Wiemann M
    Nanomedicine (Lond); 2014 Nov; 9(16):2557-85. PubMed ID: 25490426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety considerations for graphene: lessons learnt from carbon nanotubes.
    Bussy C; Ali-Boucetta H; Kostarelos K
    Acc Chem Res; 2013 Mar; 46(3):692-701. PubMed ID: 23163827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation analysis between intracellular distribution of nanomateriarls, ROS generation and DNA damage].
    Yoshida T; Yoshikawa T; Nabeshi H; Tsutsumi Y
    Yakugaku Zasshi; 2012; 132(3):295-300. PubMed ID: 22382833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of biological influence of nano-materials using toxicokinetic and toxicoproteomic approach].
    Yoshikawa T; Nabeshi H; Yoshioka Y
    Yakugaku Zasshi; 2008 Dec; 128(12):1715-25. PubMed ID: 19043290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of researches on chronic effects by manufactured nanomaterials].
    Hirose A; Takagi A; Nishimura T; Tsuda H; Sakamoto Y; Ogata A; Nakae D; Hino O; Kanno J
    Yakugaku Zasshi; 2011 Feb; 131(2):195-201. PubMed ID: 21297361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials.
    Nagai H; Toyokuni S
    Arch Biochem Biophys; 2010 Oct; 502(1):1-7. PubMed ID: 20599674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials and neurodegeneration.
    Migliore L; Uboldi C; Di Bucchianico S; Coppedè F
    Environ Mol Mutagen; 2015 Mar; 56(2):149-70. PubMed ID: 25627719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicoproteomic evaluation of carbon nanomaterials in vitro.
    Haniu H; Matsuda Y; Usui Y; Aoki K; Shimizu M; Ogihara N; Hara K; Okamoto M; Takanashi S; Ishigaki N; Nakamura K; Kato H; Saito N
    J Proteomics; 2011 Nov; 74(12):2703-12. PubMed ID: 21406258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology in cosmetics.
    Katz LM; Dewan K; Bronaugh RL
    Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between Carbon Nanomaterials and Biomolecules.
    Han X; Li S; Peng Z; Al-Yuobi AO; Omar Bashammakh AS; El-Shahawi MS; Leblanc RM
    J Oleo Sci; 2016; 65(1):1-7. PubMed ID: 26666276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.